Minims chloramphenicol 0.5%

Overdose

Treatment: hemosorption, symptomatic therapy.

Shelf life

30 months.

Contraindications

acute intermittent porphyria,

lactation period,

Incompatibilities

Concomitant administration of drugs that inhibit hematopoiesis (sulfonamides, cytostatics), which affect the metabolism in the liver, with radiation therapy increases the risk of side effects.

List of excipients

Borax

Boric acid

Purified water

Pharmaceutical form

Substance-powder

Undesirable effects

Liniment

skin rash, angioedema.

Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.

Therapeutic indications

PillsPowder for the preparation of a solution for intravenous and intramuscular administrationLinimentAerosol for external use

Diseases caused by sensitive microorganisms:

brain abscess,

typhoid fever,

salmonellosis (mainly generalized forms),

Ku fever,

pneumonia,

biliary tract infections,

typhoid fever,

Ku fever,

yersiniosis,

Pharmacotherapeutic group

  • Other synthetic antibacterial agents in combinations

Pharmacodynamic properties

A broad-spectrum bacteriostatic antibiotic that disrupts the process of protein synthesis in the microbial cell at the stage of transfer of t-RNA amino acids to ribosomes. It is effective against bacterial strains resistant to penicillins, tetracyclines, and sulfonamides.

, , Salmonella spp., Streptococcus spp., (incl. ), Haemophilus influenzae

Mycobacterium tuberculosisAcinetobacter spp.Enterobacter spp.Serratia marcescens, protozoa and fungi.

Pharmacokinetic properties

after intravenous administration-1-1. 5 h. V

max in the cerebrospinal fluid, it is determined in 4-5 hours after a single oral administration and can reach 21-50% of C in the absence of inflammation of the meninges

The main amount (90%) is metabolized in the liver. In the intestine, under the influence of intestinal bacteria, it is hydrolyzed to form inactive metabolites.

in children from 1 month to 16 years-3-6. 5 hours, in newborns from 1 to 2 days-24 hours or more (especially varies in children with low birth weight), 10-16 days — 10 hours.

It is poorly excreted during hemodialysis.

Date of revision of the text

May 2016

Name of the medicinal product

Minims Chloramphenicol 0.5%

Marketing authorisation holder

Bausch & Lomb UK Limited

Bausch & Lomb House

106 London Road

Kingston-Upon-Thames

Surrey, UK

KT2 6TN

Special precautions for storage

At a temperature not exceeding 25 °C. After opening, store the drug in the refrigerator at t 2-8 °C, use for 15 days.

powder for the preparation of eye drops 120 mg — 2 years.

Nature and contents of container

Powder for making eye drops
 
 

colistimethate sodium

in aluminum tubes of 5 g, in a pack of cardboard 1 tube.

Marketing authorisation number(s)

PL 03468/0069

Minims Chloramphenicol 0.5% price

We have no data on the cost of the drug.
However, we will provide data for each active ingredient

Qualitative and quantitative composition

Special warnings and precautions for use

In severe infections topical use of chloramphenicol should be supplemented with appropriate systemic treatment.

Aplastic anaemia has, rarely, followed topical use of chloramphenicol eye drops and, whilst this hazard is an uncommon one, it should be borne in mind when the benefits of the use of chloramphenicol are assessed.

Prolonged use should be avoided as it may increase the likelihood of sensitisation and the emergence of resistant organisms.

Contact lenses should be removed during the period of treatment.

Systemic absorption may be reduced by compressing the lacrimal sac at the medial canthus for a minute during and following the instillation of the drops. (This blocks the passage of the drops via the naso lacrimal duct to the wide absorptive area of the nasal and pharyngeal mucosa. It is especially advisable in children.)

Effects on ability to drive and use machines

May cause transient blurring of vision on installation. Warn patients not to drive or operate hazardous machinery unless vision is clear.

Dosage (Posology) and method of administration

Powder for the preparation of a solution for intravenous and intramuscular administration

V/vin/m

Cracked nipples — after each feeding, the nipples are washed with a 0.25% solution of ammonia, then a sterile cloth covered with a layer of liniment is applied to the crack.

On the skin, spray from a distance of 20-30 cm for 1-3 seconds 2-3 times a week, with severe lesions, the drug can be used daily.

Special precautions for disposal and other handling

Each Minims unit should be discarded after a single use.

If the product is to be stored unrefrigerated at temperatures not exceeding 25°C, prior to supply of the product by the pharmacy the adhesive label provided in the carton should be completed and affixed over the bar code, by a pharmacist. An expiry date one month from the supply date, plus the pharmacist's initials should be written in the spaces provided on this label.

Date of first authorisation/renewal of the authorisation

Date of Grant:

Date of Renewal:

31.7.91

23.4.97